[1]
Salih, S.R. et al. 2025. Dual Drug Repurposing in Cervical Cancer: The Synergistic Cytotoxic Effect of Dapagliflozin-Etoricoxib and Its Predicted Modulation of PI3K/Akt/mTOR Signaling via Molecular Docking. Asian Pacific Journal of Cancer Biology. 10, 4 (Oct. 2025), 821–835. DOI:https://doi.org/10.31557/apjcb.2025.10.4.821-835.